PL2399583T3 - Zastosowanie podawanych dopochwowo środków uwrażliwiających na insulinę - Google Patents
Zastosowanie podawanych dopochwowo środków uwrażliwiających na insulinęInfo
- Publication number
- PL2399583T3 PL2399583T3 PL10743433.4T PL10743433T PL2399583T3 PL 2399583 T3 PL2399583 T3 PL 2399583T3 PL 10743433 T PL10743433 T PL 10743433T PL 2399583 T3 PL2399583 T3 PL 2399583T3
- Authority
- PL
- Poland
- Prior art keywords
- vaginally
- sensitizing agents
- insulin sensitizing
- administered insulin
- administered
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 230000001235 sensitizing effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200900448A ES2344183B1 (es) | 2009-02-18 | 2009-02-18 | Uso de agentes sensibilizantes a insulina por via vaginal. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2399583T3 true PL2399583T3 (pl) | 2016-09-30 |
Family
ID=42537373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10743433.4T PL2399583T3 (pl) | 2009-02-18 | 2010-02-16 | Zastosowanie podawanych dopochwowo środków uwrażliwiających na insulinę |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20120004271A1 (pl) |
| EP (1) | EP2399583B1 (pl) |
| BR (1) | BRPI1005950A2 (pl) |
| CY (1) | CY1117425T1 (pl) |
| DK (1) | DK2399583T3 (pl) |
| ES (2) | ES2344183B1 (pl) |
| HR (1) | HRP20160280T1 (pl) |
| HU (1) | HUE027369T2 (pl) |
| PL (1) | PL2399583T3 (pl) |
| RU (1) | RU2567334C2 (pl) |
| SI (1) | SI2399583T1 (pl) |
| SM (1) | SMT201600101B (pl) |
| WO (1) | WO2010094821A1 (pl) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5457109A (en) * | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| US5874454A (en) * | 1993-09-15 | 1999-02-23 | Warner-Lambert Company | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| FR2774591B1 (fr) * | 1998-02-12 | 2000-05-05 | Lipha | Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie |
| US6100300A (en) * | 1998-04-28 | 2000-08-08 | Bristol-Myers Squibb Company | Metformin formulations and method for treating intermittent claudication employing same |
| RU2201225C2 (ru) * | 1999-04-06 | 2003-03-27 | Зыкова Татьяна Алексеевна | Способ лечения хронической ановуляции и профилактики синдрома гиперстимуляции яичников |
| US7105489B2 (en) * | 2002-01-22 | 2006-09-12 | Amylin Pharmaceuticals, Inc. | Methods and compositions for treating polycystic ovary syndrome |
| WO2003066061A1 (en) * | 2002-02-07 | 2003-08-14 | Pfizer Limited | Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome |
| WO2003068209A1 (en) * | 2002-02-14 | 2003-08-21 | Sonus Pharmaceuticals, Inc. | Metformin salts of lipophilic acids |
-
2009
- 2009-02-18 ES ES200900448A patent/ES2344183B1/es active Active
-
2010
- 2010-02-16 PL PL10743433.4T patent/PL2399583T3/pl unknown
- 2010-02-16 RU RU2011135702/15A patent/RU2567334C2/ru active
- 2010-02-16 BR BRPI1005950A patent/BRPI1005950A2/pt not_active Application Discontinuation
- 2010-02-16 WO PCT/ES2010/000067 patent/WO2010094821A1/es active Application Filing
- 2010-02-16 ES ES10743433.4T patent/ES2569538T3/es active Active
- 2010-02-16 SI SI201031169A patent/SI2399583T1/sl unknown
- 2010-02-16 HU HUE10743433A patent/HUE027369T2/hu unknown
- 2010-02-16 EP EP10743433.4A patent/EP2399583B1/en active Active
- 2010-02-16 DK DK10743433.4T patent/DK2399583T3/en active
- 2010-02-16 US US13/201,991 patent/US20120004271A1/en not_active Abandoned
-
2016
- 2016-03-18 HR HRP20160280TT patent/HRP20160280T1/hr unknown
- 2016-04-11 CY CY20161100287T patent/CY1117425T1/el unknown
- 2016-04-12 SM SM201600101T patent/SMT201600101B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SMT201600101B (it) | 2016-07-01 |
| RU2011135702A (ru) | 2013-03-27 |
| ES2569538T3 (es) | 2016-05-11 |
| WO2010094821A1 (es) | 2010-08-26 |
| CY1117425T1 (el) | 2017-04-26 |
| ES2344183B1 (es) | 2011-06-10 |
| US20120004271A1 (en) | 2012-01-05 |
| RU2567334C2 (ru) | 2015-11-10 |
| ES2344183A1 (es) | 2010-08-19 |
| BRPI1005950A2 (pt) | 2016-02-10 |
| EP2399583A1 (en) | 2011-12-28 |
| HUE027369T2 (hu) | 2016-09-28 |
| DK2399583T3 (en) | 2016-04-18 |
| EP2399583B1 (en) | 2016-01-27 |
| SI2399583T1 (sl) | 2016-06-30 |
| EP2399583A4 (en) | 2012-08-15 |
| HRP20160280T1 (hr) | 2016-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10202010801RA (en) | Use of ultrarapid acting insulin | |
| IL237581B (en) | Derivatives of 6-oxo-pyrazinopyrrolopyrimidines | |
| ZA201301120B (en) | Heterocyclic compound and use thereof | |
| IL215516A0 (en) | Emulsions of perfluorocarbons | |
| EP2464227A4 (en) | COMPOUNDS AND METHODS OF USE | |
| GB201215633D0 (en) | Use of autotransformer-like atennas for downhole applications | |
| IL215865B (en) | Meloxicam formulation | |
| EP2604597A4 (en) | HETEROCYCLIC COMPOUND AND USE THEREOF | |
| EP2455380A4 (en) | Heterocyclic compound and its use | |
| HK1160925A1 (zh) | 組織蛋白酶 的用途 | |
| ZA201205057B (en) | Fungicidal compounds and methods of their use | |
| ZA201003844B (en) | Delivery of functional compounds | |
| IL215265A0 (en) | Syringe for single use | |
| HK1173139A1 (en) | Fluorinated derivatives of 3-hydroxypyridin-4-ones 3--4- | |
| HK1131039A1 (en) | Pharmaceutical use of sophoricoside | |
| EP2617726A4 (en) | DIABETES THERAPEUTIC | |
| PL2566419T3 (pl) | Orteza | |
| PL2399583T3 (pl) | Zastosowanie podawanych dopochwowo środków uwrażliwiających na insulinę | |
| HK1160777A1 (en) | Novel use of neohesperidoside | |
| HU1000688D0 (en) | Use of trifluoro-phal | |
| GB201018482D0 (en) | Crystal structure of isoglutaminyl cyclase | |
| GB0908609D0 (en) | New use of isoQC inhibitors | |
| GB201009614D0 (en) | Therapeutic use of compounds | |
| GB0916020D0 (en) | Use of steroid compounds | |
| GB201004479D0 (en) | Therapeutic use of new compounds I |